BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28509121)

  • 1. Antithyroid drug-associated MPO-ANCA-positive tubulointerstitial nephritis in a type 2 diabetes patient: a case report.
    Nishimura S; Nakao K; Takeda M; Matsuura I; Nomura Y; Shojima S; Yamamura Y; Fujita K; Momoki N; Maruyama K; Yamamura M; Hiramatsu M
    CEN Case Rep; 2017 May; 6(1):22-28. PubMed ID: 28509121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis induced by propylthiouracil (PTU)].
    Kato H; Osajima A; Tanaka H; Serino R; Kabashima N; Tamura M; Segawa K; Anai H; Takasugi M; Nakajima Y
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):517-22. PubMed ID: 9283219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of Grave's disease with MPO-ANCA-associated glomerulonephritis during propylthiouracil (PTU) therapy following interstitial pneumonitis].
    Saeki T; Miyamura S; Nakano M; Arakawa M
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):167-71. PubMed ID: 9134835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
    Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
    BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP-VAS 2012 case report: an atypical case of microscopic polyangiitis presenting with acute tubulointerstitial nephritis without glomerular change.
    Kasahara H; Hiroyuki N; Shinohara M; Koike T
    CEN Case Rep; 2014 May; 3(1):1-4. PubMed ID: 28509258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.
    Ueda H; Ishimura E; Yunoki T; Tsuchida T; Matsumoto N; Jono S; Imanishi Y; Inaba M; Nishizawa Y
    Clin Exp Nephrol; 2005 Dec; 9(4):332-334. PubMed ID: 16362162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.
    Morimoto K; Kanzaki G; Niikura T; Koike K; Matsuo N; Maruyama Y; Tsuboi N; Yokoo T
    BMC Nephrol; 2021 Aug; 22(1):294. PubMed ID: 34461843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
    Yamashita Y; Yamane K; Fujikawa R; Okubo M; Kohno N
    Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: A case report.
    Su T; Yang L; Cui Z; Wang SX; Zhao MH
    Medicine (Baltimore); 2017 May; 96(20):e6707. PubMed ID: 28514287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
    Xu X; Zhao M; Zhang Y; Guo X; Wang H
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
    Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N
    Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
    Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
    Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement.
    Chen Y; Bao H; Liu Z; Zhang H; Zeng C; Liu Z; Hu W
    J Nephrol; 2014 Apr; 27(2):159-64. PubMed ID: 24570072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of MPO-ANCA positive vasculitis associated with alveolar hemorrhage and progressive glomerulonephritis following propylthiouracil treatment, the interval was 6 years and 4 months].
    Kobayashi K; Horiguchi T; Ban N; Kuwabara K; Hata H; Hirose M; Shiga M
    Arerugi; 2009 Nov; 58(11):1530-5. PubMed ID: 20168071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of PR3-ANCA positive granulomatosis with polyangiitis recurrent with acute kidney injury after 7 years remission].
    Kawamoto S; Koda R; Yoshino A; Takeda T; Ueda Y
    Nihon Jinzo Gakkai Shi; 2014; 56(7):1097-103. PubMed ID: 25420411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
    Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.